Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.062 | 0.2 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.038 | 0.2 |
mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.13 | 0.3 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |